Cargando…

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly

Background: The selection of assays suitable for testing the potency of clinical grade multipotent mesenchymal stromal cell (MSC)-based products and its interpretation is a challenge for both developers and regulators. Here, we present a bioprocess design for the production of Wharton’s jelly (WJ)-d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grau-Vorster, Marta, Rodríguez, Luciano, del Mazo-Barbara, Anna, Mirabel, Clémentine, Blanco, Margarita, Codinach, Margarita, Gómez, Susana G., Querol, Sergi, García-López, Joan, Vives, Joaquim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562958/ https://www.ncbi.nlm.nih.gov/pubmed/31117301 http://dx.doi.org/10.3390/cells8050484

Ejemplares similares

The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton’s Jelly Stem Cells
por: Ma, Li, et al.
Publicado: (2023)

Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance
por: Vives, Joaquim, et al.
Publicado: (2022)

Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products
por: Mirabel, Clémentine, et al.
Publicado: (2018)

Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use
por: Torrents, Sílvia, et al.
Publicado: (2023)

The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021)

NR2F2 Regulates Cell Proliferation and Immunomodulation in Whartons’ Jelly Stem Cells
por: Ma, Li, et al.
Publicado: (2022)

HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study
por: Grau-Vorster, Marta, et al.
Publicado: (2019)

Evaluation of HLA-G Expression in Multipotent Mesenchymal Stromal Cells Derived from Vitrified Wharton’s Jelly Tissue
por: Mallis, Panagiotis, et al.
Publicado: (2018)

Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View
por: Muñoz-Domínguez, Noelia, et al.
Publicado: (2021)

Osteogenic commitment of Wharton’s jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application
por: Cabrera-Pérez, Raquel, et al.
Publicado: (2019)

Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton’s jelly-derived mesenchymal stem cells
por: Corotchi, Maria Cristina, et al.
Publicado: (2013)

Wharton’s jelly absence: a possible cause of stillbirth
por: Damasceno, Eduarda Bittencourt, et al.
Publicado: (2013)

Antibacterial and Immunomodulatory Properties of Acellular Wharton’s Jelly Matrix
por: Dubus, Marie, et al.
Publicado: (2022)

Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton’s Jelly
por: Sypecka, Monika, et al.
Publicado: (2022)

Human Wharton’s jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment
por: Cabrera-Pérez, Raquel, et al.
Publicado: (2023)

Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic Source
por: Laroye, Caroline, et al.
Publicado: (2019)

Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017)

The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)

AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
por: Gupta, Ashim, et al.
Publicado: (2020)

Decellularization of Wharton’s Jelly Increases Its Bioactivity and Antibacterial Properties
por: Dubus, M., et al.
Publicado: (2022)

Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy
por: Grau-Vorster, Marta, et al.
Publicado: (2020)

Large-scale expansion of Wharton’s jelly-derived mesenchymal stem cells on gelatin microbeads, with retention of self-renewal and multipotency characteristics and the capacity for enhancing skin wound healing
por: Zhao, Guifang, et al.
Publicado: (2015)

Proteome analysis of human Wharton's jelly cells during in vitro expansion
por: Angelucci, Stefania, et al.
Publicado: (2010)

Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
por: Hu, Ying, et al.
Publicado: (2013)

Effects of Wharton’s jelly-derived mesenchymal stem cells on neonatal neutrophils
por: Khan, Imteyaz, et al.
Publicado: (2014)

Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold
por: Hosseini, Seyed Mojtaba, et al.
Publicado: (2015)

Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
por: Witkowska-Zimny, Malgorzata, et al.
Publicado: (2011)

Abstract 126: Wharton’s Jelly Induces Osteogenesis In An Alveolar Cleft Model
por: Greives, Matthew R., et al.
Publicado: (2017)

Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation
por: Talebi, Mehdi, et al.
Publicado: (2020)

Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021)

Mechanisms of Wharton’s Jelly-derived MSCs in enhancing peripheral nerve regeneration
por: Shin, Young Ho, et al.
Publicado: (2023)

Isolation and characterization of Wharton’s jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system
por: Cardoso, Tereza C, et al.
Publicado: (2012)

Wharton’s jelly mesenchymal stem cells promote wound healing and tissue regeneration
por: Kamolz, Lars-Peter, et al.
Publicado: (2014)

Wharton's Jelly human Mesenchymal Stem Cell contact guidance by noisy nanotopographies
por: Jacchetti, E., et al.
Publicado: (2014)

Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
por: Davies, John E., et al.
Publicado: (2017)

Porcine Wharton’s jelly cells distribute throughout the body after intraperitoneal injection
por: Packthongsuk, Kreeson, et al.
Publicado: (2018)

Wharton Jelly Hair in a Case of Umbilical Cord Stricture and Fetal Death
por: Kim, Eun Na, et al.
Publicado: (2019)

Differentiation of Wharton's Jelly Derived Mesenchymal Stem Cells into Insulin Producing Cells
por: Ranjbaran, Hossein, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c84dif3r46a5355bhv35tbntgg